By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Scientists at Ghent University in Belgium will use Roche's LightCycler 1536 in various cancer research projects, the company said today.

Ghent researchers will use the technology for multi-gene expression signature profiling on cancer research samples and for digital PCR for sensitive detection of mutant cancer cells in a background of normal cells.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The US Food and Drug Administration has approved Kite Pharmaceuticals' CAR T-cell therapy for large B-cell lymphomas, the New York Times reports.

Kaiser Health News reports that gene therapies could cost more than a million dollars.

Worcester Polytechnic Institute researchers have received a grant to combine biology and computer science for high school students.

In Nature this week: variants associated with obsessive-compulsive disorder, review of key CRISPR enzymes, and more.